tiprankstipranks
Trending News
More News >
Vectus Biosystems Limited (AU:VBS)
:VBS
Australian Market
Advertisement

Vectus Biosystems Limited (VBS) Price & Analysis

Compare
2 Followers

VBS Stock Chart & Stats


Vectus Biosystems Limited News

VBS FAQ

What was Vectus Biosystems Limited’s price range in the past 12 months?
Vectus Biosystems Limited lowest share price was AU$0.04 and its highest was AU$0.20 in the past 12 months.
    What is Vectus Biosystems Limited’s market cap?
    Vectus Biosystems Limited’s market cap is AU$3.20M.
      When is Vectus Biosystems Limited’s upcoming earnings report date?
      Vectus Biosystems Limited’s upcoming earnings report date is Feb 20, 2026 which is in 145 days.
        How were Vectus Biosystems Limited’s earnings last quarter?
        Vectus Biosystems Limited released its earnings results on Aug 29, 2025. The company reported -AU$0.013 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.013.
          Is Vectus Biosystems Limited overvalued?
          According to Wall Street analysts Vectus Biosystems Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Vectus Biosystems Limited pay dividends?
            Vectus Biosystems Limited does not currently pay dividends.
            What is Vectus Biosystems Limited’s EPS estimate?
            Vectus Biosystems Limited’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Vectus Biosystems Limited have?
            Vectus Biosystems Limited has 53,333,332 shares outstanding.
              What happened to Vectus Biosystems Limited’s price movement after its last earnings report?
              Vectus Biosystems Limited reported an EPS of -AU$0.013 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Vectus Biosystems Limited?
                Currently, no hedge funds are holding shares in AU:VBS

                Company Description

                Vectus Biosystems Limited

                Vectus Biosystems Limited (VBS) is an Australian biotechnology company specializing in the development of novel treatments for fibrosis and high blood pressure. The company's core focus is on creating small molecule drugs aimed at treating fibrotic diseases, which are conditions characterized by the thickening and scarring of connective tissue. Vectus Biosystems is committed to addressing unmet medical needs through its innovative research and development efforts, and its leading product candidate is VB0004, which targets the fibrosis and hypertension markets.

                Vectus Biosystems Limited (VBS) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Biotron
                Regeneus Ltd.
                AdAlta Ltd.
                Anatara Lifesciences Ltd
                Hexima Ltd
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis